 |
FDA Approval Activities for this Drug
Pristiq (desvenlafaxine succinate) Extended Release Tablets, Wyeth Pharma, Approval | Pristiq (desvenlafaxine succinate) Extended-Release Tablets, Wyeth Pharmaceuticals, Inc., Labeling Revision | Pristiq (desvenlafaxine succinate) Extended-Release Tablets, Wyeth Pharmaceuticals Inc., Control Supplement | Pristiq (desvenlafaxine succinate) Tablets, Wyeth Pharmaceuticals, Labeling Revision | Pristiq (desvenlafaxine succinate) Extended-Release Tablets, Wyeth Pharmaceuticals, Inc., Labeling Revision | Pristiq (desvenlafaxine succinate) Extended-Release Tablets, Wyeth Pharmaceuticals, Inc., Labeling Revision | Pristiq (desvenlafaxine succinate) Extended-Release Tablets, Wyeth Pharmaceuticals, Inc., Labeling Revision | Pristiq (desvenlafaxine succinate) Extended-Release Tablets, Wyeth Pharmaceuticals, Labeling Revision | Pristiq (desvenlafaxine succinate) Exented-Release Tablets, Pfizer, Supplement | Pristiq (desvenlafaxine) Extended-Release Tablets, Wyeth Pharmaceuticals, Inc., Labeling Revision | Pristiq (desvenlafaxine succinate) Extended-Release Tablets, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer, Labeling Revision | Pristiq, desvenlafaxine succinate, Tablet, Extended Release; Oral, Wyeth Pharms Inc, Labeling Revision | Pristiq, desvenlafaxine succinate, Tablet, Extended Release; Oral, Wyeth Pharms Inc, Labeling Revision | Pristiq, desvenlafaxine succinate, Tablet, Extended Release; Oral, Wyeth Pharms Inc, Efficacy Supplement with Clinical Data to Support | Pristiq, desvenlafaxine succinate, Tablet, Extended Release; Oral, Wyeth Pharms Inc, Labeling Revision | Desvenlafaxine, desvenlafaxine, Tablet, Extended Release; Oral, Alembic Pharms Ltd, Approval | Pristiq, desvenlafaxine succinate, Tablet, Extended Release; Oral, Wyeth Pharms Inc, Manufacturing Change or Addition
^ FDA's latest approval appears at the bottom of this list. ^
|